111004 ⎘
ssRNA viruses negative-sense; Details; Paramyxoviridae; Respirovirus, e.g. Bovine, human parainfluenza 1,3 Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
PRE-FUSION HUMAN PIV1 F PROTEINS
#2BETACORONAVIRUS mRNA VACCINES
#3BETACORONAVIRUS mRNA VACCINES
#4PREFUSION PIV F IMMUNOGENS AND THEIR USE
#5IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#6METHODS OF INHIBITING PARAMYXOVIRIDAE FUSION TO A TARGET CELL
#7BETACORONA VIRUS mRNA VACCINES
#8BETACORONAVIRUS mRNA VACCINES
#9A SARS-COV-2 Human Parainfluenza Virus Type 3-Vectored Vaccine
#10HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES
#11COMBINATION HMPV/RSV RNA VACCINES
#12Betacoronavirus RNA vaccines
#13COMBINATION HMPV/RSV RNA VACCINES
#14COMBINATION HMPV/RSV RNA VACCINES
#15RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF
#16RSV IMMUNIZATION REGIMEN
#17COMPOSITIONS AND METHODS FOR PREVENTING RSV AND PIV3 INFECTIONS
#18RECOMBINANT CHIMERIC BOVINE/HUMAN PARAINFLUENZA VIRUS 3 EXPRESSING SARS-COV-2 SPIKE PROTEIN AND ITS USE
#19Stabilized Pre-Fusion PIV3 F Proteins
#20PREFUSION PIV F IMMUNOGENS AND THEIR USE
#21Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof
#22RSV immunization regimen
#23BROADLY PROTECTIVE BOVINE PARAINFLUENZA 3 VIRUS AND BOVINE VIRAL DIARRHEA VIRUS VACCINE
#24MULTI-RESPIRATORY VIRUS ANTIGEN-SPECIFIC T CELLS AND METHODS OF MAKING AND USING THE SAME THERAPEUTICALLY
#25Prefusion PIV F immunogens and their use
#26Zoonotic disease RNA vaccines
#27Combination HMPV/RSV RNA vaccines
#28Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#29Liquid vaccines of live enveloped viruses
#30Composition comprising iscom particles and live micro-organisms
#31Betacoronavirus mRNA vaccine
#32Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof
#33Betacoronavirus mRNA vaccine
#34Respiratory virus nucleic acid vaccines
#35Porcine parainfluenza virus type 1 isolates and immunogenic compositions therefrom
#36Prefusion PIV F immunogens and their use
#37RSV immunization regimen
#38HPIV3 RNA vaccines
#39hMPV RNA vaccines
#40Composition comprising iscom particles and live micro-organisms
#41Combination PIV3/hMPV RNA vaccines
#42Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof
#43Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#44Anti-vaccine using sendai virus as vector
#45Canine adenovirus vectors
#46Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#47Combination PIV3/hMPV RNA vaccines
#48Modified Sendai virus vaccine and imaging vector
#49strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#50Vaccine to protect a ruminant against pneumonia caused by mannheimia haemolytica
#51Compositions and methods comprising hydrocarbon-stapled polypeptides
#52Compositions comprising iscom particles and live micro-organisms
#53Bovine virus vaccines that are liquid stable
#54CROSS-PROTECTION OF BOVINES AGAINST B. trehalosi INFECTION BY A MULTI-VALENT VACCINE
#55Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
#56Liquid stable virus vaccines
#57Paramyxovirus immunogens and related materials and methods
#58Alphavirus vectors for respiratory pathogen vaccines
#59Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#60Liquid stable bovine virus vaccines
#61Bovine virus vaccines that are liquid stable
#62Modified Sendai virus vaccine and imaging vector
#63Compositions and methods for vaccinating cattle
#64Liquid stable virus vaccines
#65RSV immunization regimen
#66Methods for producing yeast-based vaccines
#67Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules
#68Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
#69Recombinant Parainfluenza Virus Expression Systems And Vaccines
#70COMPOSITIONS AND METHODS FOR VACCINATING CATTLE
#71Vaccine
#72PRODUCTION OF ATTENUATED NEGATIVE STRANDED RNA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
#73RECOMBINANT PARAINFLUENZA VIRUS VACCINE COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM RESPIRATORY SYNCYTIAL VIRUS
#74INFLUENZA VIRUS COMPOSITIONS AND METHODS FOR UNIVERSAL VACCINES
#75CONJUGATES UTILIZING PLATFORM TECHNOLOGY FOR STIMULATING IMMUNE RESPONSE
#76Compositions and methods for the treatment of viral infections
#77RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1
#78Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
#79COMPOSITION COMPRISING ISCOM PARTICLES AND LIVE MICRO-ORGANISMS
#80Alphavirus Vectors for Respiratory Pathogen Vaccines
#81HUMAN PARAINFLUENZA VIRUSES HAVING SEPARATED P AND C GENES
#82Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#83Polyvalent chimeric rubella virus-based vaccines
#84Yeast-based vaccines
#85Method of treating pregnant cows and/or heifers
#86Recombinant parainfluenza virus expression systems and vaccines
#87Chemically defined vaccine stabiliser
#88Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#89Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences
#90Inactivated bovine herpes virus-1 and methods
#91Alphavirus Vectors for Respiratory Pathogen Vaccines
#92PRODUCTION OF ATTENUATED NEGATIVE STRANDED RNA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
#93Virus-like particles as vaccines for paramyxovirus
#94Recombinant parainfluenza virus expression systems and vaccines
#95Vaccine For Periodontal Disease
#96Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
#97Method for producing storage stable viruses and immunogenic compositions thereof
#98CD40 ligand adjuvant for respiratory syncytial virus
#99Attenuated parainfluenza virus (PIV) vaccines
#100Recombinant Parainfluenza Virus Expression Systems And Vaccines Comprising Heterologous Antigens Derived From Respiratory Syncytial Virus
#101Composition comprising iscom particles and live micro-organisms
#102Glycolipid adjuvant compositions
#103Virus-like particles as vaccines for paramyxovirus
#104Methods for preventing cattle reproductive diseases
#105Methods for preventing cattle reproductive diseases
#106Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
#107Fusogenic, self-propagating blebs as immunogenic compositions
#108Use of sendai virus as a human parainfluenza vaccine
#109Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines
#110Production of attenuated negative stranded RNA virus vaccines from cloned nucleotide sequences
#111Recombinant parainfluenza virus expression systems and vaccines
#112Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#113Vaccine for periodontal disease